Zurueck zur Suche

Reporte zur Charge 025J20A-2A

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CA 1 OK 1 KS 1 NM 1

VAERS 1536776

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 025j20a-2a

moderat
Staat
CA
Alter
42,0
Geschlecht
F
Eingang
09.08.2021
Impfdatum
26.12.2020
Beginn
27.12.2020
Tage bis Beginn
1,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Migraine

Symptomtext

Migraine; A spontaneous report was received from a nurse, 42 year old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a migraine. The patient's medical history included migraine. No relevant concomitant medications were reported. On 26 Dec 2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 27 Dec 2020, within 24 hours of vaccine administration, the patient developed a migraine. The patient stated that she had an appointment with her neurologist for a botulinum toxin injection on the day of the event but was advised by the doctor to report her side effects. The consumer stated being treated for migraines, but they have been cyclic/hormonal. Treatment information included sumatriptan, ibuprofen and caffeine, "all the usuals". Action taken with mRNA-1273 in response to the event was not reported. The event, migraine, was considered not resolved.; Reporter's Comments: This case concerns a 42-years-old female patient, with past medical history of migraine, who experienced a non-serious unexpected event of migraine. The events occurred 2 days after first dose of mRNA-1273, lot # 025J20A-2A. Treatment included sumatriptan, ibuprofen and caffeine. Based on the current available information and temporal association between the use of the product and onset of the event a causal relationship cannot be excluded. Additional information has been requested.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Migraine
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: No adverse event (no reported medical history)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1543838

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 025J20A-2A

mild
Staat
OK
Alter
-
Geschlecht
F
Eingang
11.08.2021
Impfdatum
30.12.2020
Beginn
30.12.2020
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dry mouth Injection site pain

Symptomtext

dry mouth, so she got up in the middle of the night; little sore in the injection site; This spontaneous case was reported by a patient and describes the occurrence of DRY MOUTH (dry mouth, so she got up in the middle of the night) and INJECTION SITE PAIN (little sore in the injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A-2A) for COVID-19 vaccination. Concurrent medical conditions included Diabetes. Concomitant products included SEMAGLUTIDE (OZEMPIC) for Diabetes. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced DRY MOUTH (dry mouth, so she got up in the middle of the night) and INJECTION SITE PAIN (little sore in the injection site). The patient was treated with IBUPROFEN at an unspecified dose and frequency and ACETYLSALICYLIC ACID (ALKA SELTZER PLUS [ACETYLSALICYLIC ACID]) at an unspecified dose and frequency. At the time of the report, DRY MOUTH (dry mouth, so she got up in the middle of the night) and INJECTION SITE PAIN (little sore in the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was linked to MOD-2021-013713 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Diabetes
Andere Medikamente
OZEMPIC
Allergien
-
Vorherige Impfungen
-

VAERS 1551885

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 025J20A-2A

gering
Staat
KS
Alter
45,0
Geschlecht
F
Eingang
13.08.2021
Impfdatum
28.12.2020
Beginn
06.01.2021
Tage bis Beginn
9,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Illness SARS-CoV-2 test positive

Symptomtext

Mild illness; Tested positive for COVID; This spontaneous case was reported by a nurse and describes the occurrence of ILLNESS (Mild illness) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A-2A) for COVID-19 vaccination. No Medical History information was reported. On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced ILLNESS (Mild illness). At the time of the report, ILLNESS (Mild illness) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. She tested positive for COVID on 1/6/2021 via nasal swab PCR. Concomitant medications were not reported. Treatment information were not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Illness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1536928

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 025j20a-2a

gering
Staat
NM
Alter
-
Geschlecht
F
Eingang
09.08.2021
Impfdatum
23.12.2020
Beginn
23.12.2020
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Swelling

Symptomtext

Swelling; Redness; A spontaneous report was received from a healthcare professional concerning a 61-year-old, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced swelling and redness. The patient's medical history was not provided. No relevant concomitant medications were reported. On 23 Dec 2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the arm for prophylaxis of COVID-19 infection. On 30 Dec 2020, the patient reported having a slight reaction from the vaccine she was administered a week ago. On 23 Dec 2020, she experienced swelling and redness. It was stated that "the median length for the site reaction for 2-3 days". Treatment was not provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of events swelling and redness was unknown.; Reporter's Comments: This case concerns a 61 year-old, female patient, who experienced events of swelling and redness. The events occurred the same day after the first and last dose of mRNA-1273 vaccine administration. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded and the events are assessed as possibly related.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: No adverse event (No reported medical history)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-